Fuller & Thaler Asset Management, Inc. United Therapeutics Corp Transaction History
Fuller & Thaler Asset Management, Inc.
- $25.4 Billion
- Q1 2025
A detailed history of Fuller & Thaler Asset Management, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Fuller & Thaler Asset Management, Inc. holds 491,127 shares of UTHR stock, worth $160 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
491,127
Previous 532,914
7.84%
Holding current value
$160 Million
Previous $188 Million
19.48%
% of portfolio
0.6%
Previous 0.73%
Shares
21 transactions
Others Institutions Holding UTHR
# of Institutions
733Shares Held
43.6MCall Options Held
124KPut Options Held
122K-
Black Rock Inc. New York, NY5.47MShares$1.78 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.45 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$871 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$726 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$686 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14.8B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...